dosing glp-1 Microdosing 2026: 0.1mg Chart + Tolerance Schedule Guide Microdosing GLP-1's for Weight Loss

As more evidence becomes available on the GLP-1s, expect the halo impact on overlapping comorbidities to accelerate their adoption

The approval of semaglutide for chronic weight management has fundamentally changed obesity medicine, and semaglutide training for physicians has become an urgent clinical priority

Women in their 40s navigating perimenopause face unique metabolic and hormonal shifts that may influence how GLP-1 medications interact with their physiology

Learn about the OKV-119 implant for feline obesity, the MEOW-1 clinical trial, and evidence-based strategies to help your cat today.

See who qualifies

The presence of diabetes promotes the progression of simple fatty liver to non-alcoholic steatohepatitis (NASH) and cirrhosis, and the presence of NAFLD increases the risk of diabetic complications